wow-inequalities/02-data/intermediate/wos_sample/0fa2371c5452f58018eac37a6a2f3bab-tantivess-sripen-an/info.yaml

abstract: 'Capacity is limited in the developing world to conduct

  cost-effectiveness analysis (CEA) of health interventions. In Thailand,

  there have been concerted efforts to promote evidence-based policy

  making, including the introduction of economic, appraisals within health

  technology assessment (HTA). This paper reviews the experience of this

  lower middle-income country, with an emphasis on the creation of the

  Health Intervention and Technology Assessment Program (HITAP), including

  its mission, management structures and activities.

  Over the past 3 decades, several HTA programmes were implemented in

  Thailand but not sustained or developed further into a national

  institute. As a response to increasing demands for HTA evidence

  including CEA information, the HITAP was created in 2007 as an affiliate

  unit of a semi-autonomous research arm of the Ministry Of Public Health.

  An advantage of this HTA programme over previous initiatives was that it

  was hosted by a research institute with long-term experience in

  conducting health systems and policy research and capacity building of

  its research staff, and excellent research and policy networks. To deal

  with existing impediments to conducting health economics research, the

  main strategies of the HITAP were carefully devised to include not only

  capacity strengthening of its researchers and administrative staff, but

  also the development of essential elements for the country''s health

  economic evaluation methodology. These included, for example,

  methodological guidelines, standard protocols and benchmarks for

  resource allocation, many of which have been adopted by national

  policy-making bodies including the three major public health insurance

  plans. Networks and collaborations with domestic and foreign institutes

  have been sought as a means of resource mobilization and exchange.

  Although the HITAP is well financed by a number of government agencies

  and international organizations, the programme is vulnerable to

  shortages of qualified research staff, as most staff work on a part-time

  or temporary basis.

  To enhance the utilization of its research findings by policy makers,

  practitioners and consumers, the HITAP has adopted the principles of

  technical excellence, policy relevance, transparency, effective

  communication and participation of key stakeholders. These principles

  have been translated into good practice at every step of HTA management.

  In 2007 and 2008, the HITAP carried out assessments of a wide range of

  health products, medical procedures and public health initiatives.

  Although CEA and other economic evaluation approaches were employed in

  these studies, the tools and underlying efficiency goal were considered

  inadequate to provide complete information for prioritization. As

  suggested by official stakeholders, some of the projects investigated

  broader issues of management, feasibility, performance and

  socio-political implications of interventions. As yet, it is unclear

  what role HITAP research and associated recommendations have played in

  policy decisions.

  It is hoped that the lessons drawn on the creation of the HITAP and its

  experience during the first 2 years, as well as information on its main

  strategies and management structures, may be helpful for other

  resource-constrained countries when considering how best to strengthen

  their capacity to conduct economic appraisals of health technologies and

  interventions.'
affiliation: 'Tantivess, S (Corresponding Author), Minist Publ Hlth, Dept Hlth, Hlth
  Intervent \& Technol Assessment Program, 6th Floor,Bldg 6, Nonthaburi 11000, Thailand.

  Tantivess, Sripen, Minist Publ Hlth, Dept Hlth, Hlth Intervent \& Technol Assessment
  Program, Nonthaburi 11000, Thailand.

  Mills, Anne, London Sch Hyg \& Trop Med, London WC1, England.'
author: Tantivess, Sripen and Teerawattananon, Yot and Mills, Anne
author-email: sripen@ihpp.thaigov.net
author_list:
- family: Tantivess
  given: Sripen
- family: Teerawattananon
  given: Yot
- family: Mills
  given: Anne
da: '2023-09-28'
doi: 10.2165/11314710-000000000-00000
files: []
issn: 1170-7690
journal: PHARMACOECONOMICS
keywords-plus: ECONOMIC-EVALUATION; POLICY; SYSTEMS
language: English
number: '11'
number-of-cited-references: '35'
orcid-numbers: 'Teerawattananon, Yot/0000-0003-2217-2930

  Mills, Anne/0000-0001-9863-9950'
pages: 931-945
papis_id: 5a1045ceaebf78bb24ef2ee15012a3cd
ref: Tantivess2009strengtheningcosteff
tags:
- relevant
- review
times-cited: '36'
title: Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment
  of the Health Intervention and Technology Assessment Program
type: Review
unique-id: WOS:000273272300005
usage-count-last-180-days: '0'
usage-count-since-2013: '14'
volume: '27'
web-of-science-categories: 'Economics; Health Care Sciences \& Services; Health Policy
  \& Services;

  Pharmacology \& Pharmacy'
year: '2009'